Modulation of regulatory T cells in health and disease: Role of toll-like receptors

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 2, 2009, Pages 124-129

  Nyirenda, Mukanthu H ^a   O'Brien, Kate ^a   Sanvito, Lara ^a   Constantinescu, Cris S ^a   Gran, Bruno ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Autoimmune disease; Cancer immunity; Effector T cells; Regulatory T cells; Toll like receptor

Indexed keywords

LEUCINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; HUMAN; IMMUNE MEDIATED INJURY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; INFLAMMATORY DISEASE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC SURVEILLANCE; IMMUNOSUPPRESSION; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTORS; TRETINOIN;

EID: 70349481019     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809788462581     Document Type: Review

References (78)

1. Iwasaki, A.; Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol., 2004, 5, 987-995.
2. Liu, G.; Zhao, Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology, 2007, 122, 149-156.
3. Caramalho, I.; Lopes-Carvalho, T.; Ostler, D.; Zelenay, S.; Haury, M.; Demengeot, J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med., 2003, 197, 403-411.
4. Sakaguchi, S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol., 2004, 22, 531-562.
5. Baecher-Allan, C.; Hafler, D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev., 2006, 212, 203-216.
6. Fontenot, J.D.; Gavin, M.A.; Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol., 2003, 4, 330-336.
7. Hori, S.; Nomura, T.; Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299, 1057-1061.
8. Gambineri, E.; Torgerson, T.R.; Ochs, H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol., 2003, 15, 430-435.
9. Venken, K.; Hellings, N.; Broekmans, T.; Hensen, K.; Rummens, J.L.; Stinissen, P. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J. Immunol., 2008, 180, 6411-6420.
10. Seddiki, N.; Santner-Nanan, B.; Martinson, J.; Zaunders, J.; Sasson, S.; Landay, A.; Solomon, M.; Selby, W.; Alexander, S.I.; Nanan, R.; Kelleher, A.; Fazekas de St Groth, B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med., 2006, 203, 1693-1700.
11. Hartigan-O'Connor, D.J.; Poon, C.; Sinclair, E.; McCune, J.M. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods, 2007, 319, 41-52.
12. Wang, R.F. Functional control of regulatory T cells and cancer immunotherapy. Semin. Cancer Biol., 2006, 16, 106-114.
13. Asseman, C.; Mauze, S.; Leach, M.W.; Coffman, R.L.; Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med., 1999, 190, 995-1004.
14. Roncarolo, M.G.; Bacchetta, R.; Bordignon, C.; Narula, S.; Levings, M.K. Type 1 T regulatory cells. Immunol. Rev., 2001, 182, 68-79.
15. Tang, Q.; Boden, E.K.; Henriksen, K.J.; Bour-Jordan, H.; Bi, M.; Bluestone, J.A. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. Eur. J. Immunol., 2004, 34, 2996-3005.
16. von Boehmer, H. Mechanisms of suppression by suppressor T cells. Nat. Immunol., 2005, 6, 338-344.
17. Gregg, R.K.; Jain, R.; Schoenleber, S.J.; Divekar, R.; Bell, J.J.; Lee, H.H.; Yu, P.; Zaghouani, H. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol., 2004, 173, 7308-7316.
18. Akira, S. Mammalian Toll-like receptors. Curr. Opin. Immunol., 2003, 15, 5-11.
19. Akira, S.; Hemmi, H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett., 2003, 85, 85-95.
20. Pasare, C.; Medzhitov, R. Toll-like receptors and acquired immunity. Semin. Immunol., 2004, 16, 23-26.
21. O'Brien, K.; Fitzgerald, D.C.; Naiken, K.; Alugupalli, K.R.; Rostami, A.M.; Gran, B. Role of the innate immune system in autoimmune inflammatory demyelination. Curr. Med. Chem., 2008, 15, 1105-1115.
22. Miyake, K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol., 2007, 19, 3-10.
23. Ozinsky, A.; Underhill, D.M.; Fontenot, J.D.; Hajjar, A.M.; Smith, K.D.; Wilson, C.B.; Schroeder, L.; Aderem, A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA, 2000, 97, 13766-13771.
24. Takeuchi, O.; Sato, S.; Horiuchi, T.; Hoshino, K.; Takeda, K.; Dong, Z.; Modlin, R.L.; Akira, S. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol., 2002, 169, 10-14.
25. Kabelitz, D. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol., 2007, 19, 39-45.
26. Miggin, S.M.; O'Neill, L.A. New insights into the regulation of TLR signaling. J. Leukoc. Biol., 2006, 80, 220-226.
27. Janeway, C.A.Jr.; Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol., 2002, 20, 197-216.
28. Akira, S. and Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol., 2004, 4, 499-511.
29. Babu, S.; Blauvelt, C.P.; Kumaraswami, V.; Nutman, T.B. Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection. J. Immunol., 2006, 176, 3885-3889.
30. Crellin, N.K.; Garcia, R.V.; Hadisfar, O.; Allan, S.E.; Steiner, T.S.; Levings, M.K. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol., 2005, 175, 8051-8059.
31. Komai-Koma, M.; Jones, L.; Ogg, G.S.; Xu, D.; Liew, F.Y. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl. Acad. Sci. USA, 2004, 101, 3029-3034.
32. Raffeiner, B.; Dejaco, C.; Duftner, C.; Kullich, W.; Goldberger, C.; Vega, S.C.; Keller, M.; Grubeck-Loebenstein, B.; Schirmer, M. Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis. Arthritis. Res. Ther., 2005, 7, R1412-1420.
33. Heil, F.; Ahmad-Nejad, P.; Hemmi, H.; Hochrein, H.; Ampenberger, F.; Gellert, T.; Dietrich, H.; Lipford, G.; Takeda, K.; Akira, S.; Wagner, H.; Bauer, S. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol., 2003, 33, 2987-2997.
34. Hemmi, H.; Kaisho, T.; Takeuchi, O.; Sato, S.; Sanjo, H.; Hoshino, K.; Horiuchi, T.; Tomizawa, H.; Takeda, K.; Akira, S. Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol., 2002, 3, 196-200.
35. Jurk, M.; Heil, F.; Vollmer, J.; Schetter, C.; Krieg, A.M.; Wagner, H.; Lipford, G.; Bauer, S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol., 2002, 3, 499.
36. Lee, J.; Chuang, T.H.; Redecke, V.; She, L.; Pitha, P.M.; Carson, D.A.; Raz, E.; Cottam, H.B. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA, 2003, 100, 6646-6651.
37. Matsumoto, M.; Funami, K.; Tanabe, M.; Oshiumi, H.; Shingai, M.; Seto, Y.; Yamamoto, A.; Seya, T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol., 2003, 171, 3154-3162.
38. Baccala, R.; Hoebe, K.; Kono, D.H.; Beutler, B.; Theofilopoulos, A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med., 2007, 13, 543-551.
39. Nguyen, V.H.; Shashidhar, S.; Chang, D.S.; Ho, L.; Kambham, N.; Bachmann, M.; Brown, J.M.; Negrin, R.S. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood, 2008, 111, 945-953.
40. Jiang, X.; Morita, M.; Sugioka, A.; Harada, M.; Kojo, S.; Wakao, H.; Watarai, H.; Ohkohchi, N.; Taniguchi, M.; Seino, K. The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance. Liver Transpl., 2006, 12, 1112-1118.
41. Viguier, M.; Lemaitre, F.; Verola, O.; Cho, M.S.; Gorochov, G.; Dubertret, L.; Bachelez, H.; Kourilsky, P.; Ferradini, L. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol., 2004, 173, 1444-1453.
42. Ehlers, M.; Fukuyama, H.; McGaha, T.L.; Aderem, A.; Ravetch, J.V. TLR9/ MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med., 2006, 203, 553-561.
43. Visser, L.; Jan de Heer, H.; Boven, L.A.; van Riel, D.; van Meurs, M.; Melief, M.J.; Zahringer, U.; van Strijp, J.; Lambrecht, B.N.; Nieuwenhuis, E.E.; Laman, J.D. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J. Immunol., 2005, 174, 808-816.
44. Visser, L.; Melief, M.J.; van Riel, D.; van Meurs., M.; Sick, E.A.; Inamura, S.; Bajramovic, J.J.; Amor, S.; Hintzen, R.Q.; Boven, L.A.; Hart, B.A.; Laman, J.D. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am. J. Pathol., 2006, 169, 1671-1685.
45. Abdollahi-Roodsaz, S.; Joosten, L.A.; Koenders, M.I.; Devesa, I.; Roelofs, M.F.; Radstake, T.R.; Heuvelmans-Jacobs, M.; Akira, S.; Nicklin, M.J.; Ribeiro-Dias, F.; Van den Berg, W.B. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest., 2008, 118, 205-216.
46. Gribar, S.C.; Anand, R.J.; Sodhi, C.P.; Hackam, D.J. The role of epithelial Toll-like receptor signaling in the pathogenesis of intestinal inflammation. J. Leukoc. Biol., 2008, 83, 493-498.
47. Zipris, D.; Lien, E.; Xie, J.X.; Greiner, D.L.; Mordes, J.P.; Rossini, A.A. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol., 2005, 174, 131-142.
48. Chen, L.; Wang, T.; Zhou, P.; Ma, L.; Yin, D.; Shen, J.; Molinero, L.; Nozaki, T.; Phillips, T.; Uematsu, S.; Akira, S.; Wang, C.R.; Fairchild, R.L.; Alegre, M.L.; Chong, A. TLR engagement prevents transplantation tolerance. Am. J. Transplant., 2006, 6, 2282-2291.
49. Thornley, T.B.; Brehm, M.A.; Markees, T.G.; Shultz, L.D.; Mordes, J.P.; Welsh, R.M.; Rossini, A.A.; Greiner, D.L. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J. Immunol., 2006, 176, 1561-1570.
50. Touil, T.; Fitzgerald, D.; Zhang, G.X.; Rostami, A.; Gran, B. Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J. Immunol., 2006, 177, 7505-7509.
51. Rachmilewitz, D.; Karmeli, F.; Takabayashi, K.; Hayashi, T.; Leider-Trejo, L.; Lee, J.; Leoni, L.M.; Raz, E. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology, 2002, 122, 1428-1441.
52. Vijay-Kumar, M.; Wu, H.; Aitken, J.; Kolachala, V.L.; Neish, A.S.; Sitaraman, S.V.; Gewirtz, A.T. Activation of toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm. Bowel Dis., 2007, 13, 856-864.
53. Buenafe, A.C.; Bourdette, D.N. Lipopolysaccharide pretreatment modulates the disease course in experimental autoimmune encephalomyelitis. J. Neuroimmunol., 2007, 182, 32-40.
54. Marta, M.; Andersson, A.; Isaksson, M.; Kampe, O.; Lobell, A. Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis. Eur. J. Immunol., 2008, 38, 565-575.
55. Kerfoot, S.M.; Long, E.M.; Hickey, M.J.; Andonegui, G.; Lapointe, B.M.; Zanardo, R.C.; Bonder, C.; James, W.G.; Robbins, S.M.; Kubes, P. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol., 2004, 173, 7070-7077.
56. Sutmuller, R.; Garritsen, A.; Adema, G.J. Regulatory T cells and toll-like receptors: regulating the regulators. Ann. Rheum. Dis., 2007, 66 Suppl 3, 91-95.
57. Liu, H.; Komai-Koma, M.; Xu, D.; Liew, F.Y. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA, 2006, 103, 7048-7053.
58. Zanin-Zhorov, A.; Cahalon, L.; Tal, G.; Margalit, R.; Lider, O.; Cohen, I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J. Clin. Invest., 2006, 116, 2022-2032.
59. Sutmuller, R.P.; den Brok, M.H.; Kramer, M.; Bennink, E.J.; Toonen, L.W.; Kullberg, B.J.; Joosten, L.A.; Akira, S.; Netea, M.G.; Adema, G.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest., 2006, 116, 485-494.
60. Ascherio, A.; Munger, K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol., 2007, 61, 288-299.
61. Buljevac, D.; Flach, H.Z.; Hop, W.C.; Hijdra, D.; Laman, J.D.; Savelkoul, H.F.; van Der Meche, F.G.; van Doorn, P.A.; Hintzen, R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain, 2002, 125, 952-960.
62. Bach, J.F. Infections and autoimmune diseases. J. Autoimmun., 2005, 25, 74-80.
63. Peng, G.; Guo, Z.; Kiniwa, Y.; Voo, K.S.; Peng, W.; Fu, T.; Wang, D.Y.; Li, Y.; Wang, H.Y.; Wang, R.F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science, 2005, 309, 1380-1384.
64. Gelman, A.E.; LaRosa, D.F.; Zhang, J.; Walsh, P.T.; Choi, Y.; Sunyer, J.O.; Turka, L.A. The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity, 2006, 25, 783-793.
65. Porrett, P.M.; Yuan, X.; LaRosa, D.F.; Walsh, P.T.; Yang, J.; Gao, W.; Li, P.; Zhang, J.; Ansari, J.M.; Hancock, W.W.; Sayegh, M.H.; Koulmanda, M.; Strom, T.B.; Turka, L.A. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J. Immunol., 2008, 181, 1692-1699.
66. Viglietta, V.; Baecher-Allan, C.; Weiner, H.L.; Hafler, D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med., 2004, 199, 971-979.
67. Raz, I.; Elias, D.; Avron, A.; Tamir, M.; Metzger, M. and Cohen, I.R. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet, 2001, 358, 1749-1753.
68. Kubo, T.; Hatton, R.D.; Oliver, J.; Liu, X.; Elson, C.O.; Weaver, C.T. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J. Immunol., 2004, 173, 7249-7258.
69. Pasare, C.; Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science, 2003, 299, 1033-1036.
70. Fehervari, Z.; Sakaguchi, S. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int. Immunol., 2004, 16, 1769-1780.
71. Ouabed, A.; Hubert, F.X.; Chabannes, D.; Gautreau, L.; Heslan, M.; Josien, R. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J. Immunol., 2008, 180, 5862-5870.
72. Brinster, C.; Shevach, E.M. Bone marrow-derived dendritic cells reverse the anergic state of CD4+CD25+ T cells without reversing their suppressive function. J. Immunol., 2005, 175, 7332-7340.
73. Siepmann, K.; Biester, S.; Plskova, J.; Muckersie, E.; Duncan, L.; Forrester, J.V. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo. Graefes. Arch. Clin. Exp. Ophthalmol., 2007, 245, 221-229.
74. Ahn, J.S.; Krishnadas, D.K.; Agrawal, B. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood. Int. Immunol., 2007, 19, 227-237.
75. Chiffoleau, E.; Heslan, J.M.; Heslan, M.; Louvet, C.; Condamine, T.; Cuturi, M.C. TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell. Int. Immunol., 2007, 19, 193-201.
76. Gelman, A.E.; Zhang, J.; Choi, Y.; Turka, L.A. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J. Immunol., 2004, 172, 6065-6073.
77. LaRosa, D.F.; Gelman, A.E.; Rahman, A.H.; Zhang, J.; Turka, L.A.; Walsh, P.T. CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells. Immunol. Lett., 2007, 108, 183-188.
78. Johnson, C.M.; Lyle, E.A.; Omueti, K.O.; Stepensky, V.A.; Yegin, O.; Alpsoy, E.; Hamann, L.; Schumann, R.R.; Tapping, R.I. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol., 2007, 178, 7520-7524.